Positive News SentimentPositive NewsNASDAQ:CYPH Cypherpunk Technologies (CYPH) Stock Price, News & Analysis $0.60 -0.01 (-1.90%) As of 06/25/2026 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock About Cypherpunk Technologies Stock (NASDAQ:CYPH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CYPH alerts:Sign Up Key Stats Today's Range$0.59▼$0.6450-Day Range$0.52▼$1.3152-Week Range$0.23▼$3.70Volume1.51 million shsAverage Volume7.32 million shsMarket Capitalization$63.72 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Cypherpunk Technologies Inc., previously known as Leap Therapeutics, Inc., is a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The company’s research platform centers on modulating the tumor microenvironment to enhance anti-tumor immune responses. Cypherpunk’s proprietary pipeline includes DKN-01, a monoclonal antibody designed to neutralize Dickkopf-1 (DKK1), a protein implicated in tumor growth and immune evasion. DKN-01 is being evaluated both as a monotherapy and in combination with checkpoint inhibitors such as pembrolizumab across multiple solid tumor indications, including gastroesophageal, pancreatic and other advanced malignancies. In addition to DKN-01, Cypherpunk is advancing preclinical programs that target novel pathways involved in cancer cell signaling and immune regulation, with the aim of identifying complementary assets for future clinical development. Founded in 2016 and headquartered in Irvine, California, Leap Therapeutics completed its initial public offering in 2019 and now trades on the NASDAQ under the ticker CYPH. The company conducts clinical trials in the United States and collaborates with academic and industry partners to accelerate its development programs. Michael Stoll, M.D., serves as President and Chief Executive Officer, overseeing a team of experienced professionals in oncology drug discovery and development. AI Generated. May Contain Errors. Read More Cypherpunk Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks16th Percentile Overall ScoreCYPH MarketRank™: Cypherpunk Technologies scored higher than 16% of companies evaluated by MarketBeat, and ranked 836th out of 848 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingCypherpunk Technologies has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageCypherpunk Technologies has only been the subject of 1 research reports in the past 90 days.Read more about Cypherpunk Technologies' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Cypherpunk Technologies is -29.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cypherpunk Technologies is -29.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCypherpunk Technologies has a P/B Ratio of 0.33. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted6.79% of the float of Cypherpunk Technologies has been sold short.Short Interest Ratio / Days to CoverCypherpunk Technologies has a short interest ratio ("days to cover") of 0.66, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cypherpunk Technologies has recently increased by 5.02%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCypherpunk Technologies does not currently pay a dividend.Dividend GrowthCypherpunk Technologies does not have a long track record of dividend growth. News and Social Media3.7 / 5News SentimentN/A News SentimentCypherpunk Technologies has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.98 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Cypherpunk Technologies this week, compared to 2 articles on an average week.MarketBeat Follows1 people have added Cypherpunk Technologies to their MarketBeat watchlist in the last 30 days. Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cypherpunk Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders3.50% of the stock of Cypherpunk Technologies is held by insiders.Percentage Held by Institutions30.46% of the stock of Cypherpunk Technologies is held by institutions.Read more about Cypherpunk Technologies' insider trading history. Receive CYPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cypherpunk Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CYPH Stock News HeadlinesCypherpunk Technologies Reports First Quarter 2026 Financial ResultsMay 14, 2026 | prnewswire.comCypherpunk Increases its Zcash Stake, Launches New Website and Investor DashboardApril 15, 2026 | prnewswire.comYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.June 26 at 1:00 AM | Profits Run (Ad)Cypherpunk Technologies Announces Planned Board Leadership TransitionsApril 12, 2026 | theglobeandmail.comCypherpunk Technologies (NASDAQ:CYPH) Stock, Option ChainApril 10, 2026 | benzinga.comCypherpunk Technologies Rocked by Major Insider Stock SaleMarch 30, 2026 | tipranks.comCypherpunk Reports Full Year 2025 Financial ResultsMarch 16, 2026 | prnewswire.comMajor VCs Back Zcash Developers With $25 Million After ECC SplitMarch 10, 2026 | bitcoinist.comSee More Headlines CYPH Stock Analysis - Frequently Asked Questions How have CYPH shares performed this year? Cypherpunk Technologies' stock was trading at $1.16 at the beginning of 2026. Since then, CYPH stock has decreased by 48.4% and is now trading at $0.5985. How were Cypherpunk Technologies' earnings last quarter? Cypherpunk Technologies (NASDAQ:CYPH) announced its quarterly earnings data on Thursday, May, 14th. The company reported ($0.46) EPS for the quarter, missing analysts' consensus estimates of ($0.04) by $0.42. When did Cypherpunk Technologies' stock split? Shares of Cypherpunk Technologies reverse split on Wednesday, June 21st 2023.The 1-10 reverse split was announced on Wednesday, June 21st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, June 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. Who are Cypherpunk Technologies' major shareholders? Top institutional investors of Cypherpunk Technologies include Renaissance Technologies LLC (0.74%). View institutional ownership trends. How do I buy shares of Cypherpunk Technologies? Shares of CYPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/14/2026Today6/26/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (6m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 CYPH's financial health is in the Yellow zone, according to TradeSmith. CYPH has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:CYPH Previous SymbolNASDAQ:LPTX CIK1509745 Webwww.leaptx.com Phone(617) 714-0360FaxN/AEmployees40Year Founded2011Profitability EPS (Trailing Twelve Months)($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$4.82 million Net MarginsN/A Pretax MarginN/A Return on Equity-48.33% Return on Assets-42.21% Debt Debt-to-Equity RatioN/A Current Ratio27.28 Quick Ratio27.28 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.83 per share Price / Book0.33Miscellaneous Outstanding Shares106,464,000Free Float102,738,000Market Cap$63.72 million OptionableOptionable Beta-0.02 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:CYPH) was last updated on 6/26/2026 by MarketBeat.com Staff. From Our PartnersDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredGold Is About to Do Something It Hasn’t in 90 YearsThe U.S. Treasury still carries America's gold reserves at $42 per ounce — a price set generations ago. Buried...US Gold Bureau | Sponsored3 Wall St. Legends Have Same Dark Prediction for June 29thThree Wall Street legends are pointing to the same date - June 29th - as a potential turning point driven by a...TradeSmith | SponsoredSpaceX IPO “cancelled”?SpaceX is approaching what could be a $1.6 trillion IPO - potentially the largest in history. But Louis Navell...InvestorPlace | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredThe EPA just put a kill switch on Elon’s empireA federal EPA permit expires January 2, 2027 - and if Elon Musk's Colossus supercomputer loses power that day,...Behind the Markets | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely, LLC | SponsoredQuick favor to ask youBill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cypherpunk Technologies Please log in to your account or sign up in order to add this asset to your watchlist. Share Cypherpunk Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
